Penalty Amount
$103,420
The FTC distributed refunds to consumers who purchased deceptively marketed treatment plans from Golden Sunrise Nutraceutical. The company and its medical director were barred from making unsupported health claims about curing COVID-19, cancer, and Parkinson's disease after a court order in September 2025. Over $40,700 was sent to 578 consumers, with additional claims possible until May 2026.
Defendants were ordered to pay $103,420 in monetary penalties, barred from making unsupported health claims in the future, and required to provide refunds to affected consumers totaling over $40,700.
In-house legal teams should review all customer-facing agreements (including sales contracts, terms of service, and marketing partnership agreements) and vendor agreements where marketing materials or product descriptions are provided. Focus on representations and warranties clauses regarding the accuracy of marketing claims, compliance with FTC Act Section 5, and product efficacy statements. Specific clauses to scrutinize include those governing marketing material approval processes, indemnification for regulatory actions, and termination rights for breach of compliance obligations. Changes may be needed to require pre-approval of any health-related claims, mandate documented scientific evidence for efficacy statements, and include explicit prohibitions against claiming products can cure specific diseases like COVID-19, cancer, or Parkinson's without FDA review and approval.
Entity
Golden Sunrise Nutraceutical, Inc.
Also known as: Golden Sunrise Nutraceutical
Industry
HealthcareOfficial Press Release
https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-sends-checks-consumers-who-bought-certain-products-golden-sunrise-nutraceutical-between-2017
promoter 23000 covid 19 treatment plan barred making bogus h
https://www.ftc.gov/news-events/news/press-releases/2021/06/promoter-23000-covid-19-treatment-plan-barred-making-bogus-health-claims
GoldenSunrise Order
https://www.ftc.gov/system/files/ftc_gov/pdf/GoldenSunrise-Order.pdf
ftc announces refund claims process consumers who bought dec
https://www.ftc.gov/news-events/news/press-releases/2025/01/ftc-announces-refund-claims-process-consumers-who-bought-deceptively-marketed-golden-sunrise
GoldenSunrise
https://www.ftc.gov/GoldenSunrise
Federal Trade Commission Enforcement Page
https://www.ftc.gov/enforcement
"Golden Sunrise Nutraceutical, Inc."
"ordered to pay $103,420"
"deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19, and used false or unproven claims that other treatment plans could cure cancer and Parkinson’s disease"
"578 affected consumers"
"In September 2025"
"barred them from making unsupported health claims in the future"
The FTC referred a complaint against REPS & Company Inc. and company executives, alleging they bypassed ticket-issuer security controls and purchasing limits to acquire millions of tickets for resale. The complaint was filed by the Department of Justice, and the case will be decided by the court; the press release does not report a penalty or other remedy imposed.
The FTC sued Digital Forensics Corporation LLC and affiliated defendants, alleging they misled sextortion victims with promises of investigative and monitoring services that often were not provided, and used fake positive reviews. A federal court granted the FTC’s request to temporarily halt the defendants’ activities; the complaint remains for the court to decide.
The FTC alleged that Greenway Auto Group advertised vehicle prices thousands of dollars below the amounts consumers actually paid and used mailers falsely suggesting recipients had won cash prizes. Greenway agreed to an order requiring transparent pricing and prohibiting deceptive prize mailers and other misrepresentations; the press release does not state a monetary penalty.
The FTC sent warning letters to 24 large healthcare services companies, cautioning that incomplete, inaccurate, or untimely pricing information for scheduled medical care may be unfair or deceptive. The letters urge recipients to review their price-disclosure practices and take corrective action; they announce no fine or formal order.
$1.9M
The FTC alleged that Premier Franchising Group LLC and Franchise Fastlane LLC made deceptive and unsubstantiated claims about the Premier Martial Arts franchise opportunity and violated the Franchise Rule. The proposed settlements require the companies to pay a combined $1.85 million to compensate franchisees, prohibit certain misrepresentations, and require Franchise Rule compliance; certain franchisees may also cancel their agreements without penalty.
The FTC, Utah, and Nevada sued Lens.com Inc., alleging that it advertised artificially low contact lens prices while hiding mandatory checkout charges and misleading consumers about its AutoRefill subscription. The complaint seeks to stop the alleged practices; the court has not yet decided the case, and no penalty or remedy has been imposed.